Posted on March 14th, 2012 by
The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $1.35 million to University of Minnesota and Mayo Clinic researchers seeking new treatments for myelodysplastic syndrome (MDS), a cancer of the blood that impacts the way the human body develops blood cells. The grant will help support the development of pilot studies that could someday result…
Finance & Commerce by Chris Newmarker 3/14/12
You must be logged-in to the site to post a comment.